20260706_SCPI_Pemanggilan RUPS_32108872_lamp1.pdf

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




        2.     Berdasarkan Pasal 7 ayat (7) Anggaran Dasar Perseroan, yang berhak memberikan suara dalam Rapat
               tersebut adalah Pemegang Saham Perseroan yang namanya tercatat dalam Daftar Pemegang Saham
               (“DPS”) Perseroan atau pemilik saldo rekening efek di Penitipan Kolektif KSEI pada hari Kamis, 2 Juli 2026
               pukul 16.00 WIB.
        3.     Bagi para Pemegang Saham Perseroan yang sahamnya dimasukkan dalam penitipan kolektif KSEI,
               Konfirmasi Tertulis Untuk Rapat (“KTUR”) dapat diperoleh di perusahaan efek atau di Bank Kustodian
               dimana Pemegang Saham Perseroan membuka rekening efeknya.
        4.     Pemegang Saham yang tidak hadir dapat diwakili oleh kuasanya melalui e-proxy sebagaimana tersebut di
               atas dan/atau diwakili oleh kuasanya dalam Rapat dengan membawa Surat Kuasa dengan ketentuan
               anggota Direksi, anggota Dewan Komisaris dan Karyawan Perseroan dapat bertindak selaku kuasa
               pemegang saham Perseoran dalam Rapat ini, namun suara yang mereka keluarkan tidak diperhitungkan
               dalam pemungutan suara. Formulir Surat Kuasa dapat diperoleh setiap jam kerja di Biro Administrasi Efek
               (“BAE”) Perseroan, PT Ficomindo Buana Registrar, Jalan Kyai Caringin No 2-A RT 11/RW 4, Cideng,
               Gambir, Jakarta Pusat 10150, nomor telepon (021) 22638327, 22639048, and email to
               ficomindo_br@yahoo.co.id(“BAE”).
        5.     Pemegang Saham atau kuasanya yang akan menghadiri Rapat diminta untuk membawa dan menyerahkan
               fotocopy Kartu Tanda Penduduk atau Tanda Pengenal Lainnya yang masih berlaku kepada petugas
               pendaftaran sebelum memasuki ruang Rapat.
        6.     Bagi Pemegang Saham Perseroan yang berbentuk Badan Hukum seperti Perseroan Terbatas, Yayasan
               atau Dana Pensiun agat membawa fotocopy lengkap dari Anggaran Dasarnya serta susunan pengurus
               yang terakhir.
        7.     Formulir surat kuasa dan surat pernyataan Pemegang Saham Independen dapat diperoleh dan diunduh
               melalui situs web Perseroan https://www.organon.com/indonesia/ atau pada Kantor BAE. Dokumen
               tersebut wajib ditandatangani dan dibubuhi meterai. Dalam hal surat kuasa dan surat pernyataan
               Pemegang Saham Independen ditandatangani di luar wilayah Republik Indonesia maka surat kuasa dan
               surat pernyataan tersebut harus dilegalisasi oleh notaris publik setempat dan kantor perwakilan resmi
               pemerintah Republik Indonesia di negara setempat atau dilakukan Apostille sesuai ketentuan yang berlaku.
        8.     Kuorum Kehadiran dan Pengambilan Keputusan:
               •    Mata Acara Pertama: disyaratkan kehadiran lebih dari ½ (satu per dua) bagian dari jumlah seluruh
                    saham dengan hak suara sah yang dimiliki oleh Para Pemegang Saham Independen, dan keputusan
                    sah jika disetujui oleh lebih dari ½ (satu per dua) bagian dari jumlah seluruh Saham dengan hak suara
                    yang sah yang dimiliki oleh Para Pemegang Saham Independen yang hadir dalam RUPSLB Kedua.
               •    Mata Acara Kedua: disyaratkan kehadiran para pemegang saham yang mewakili paling sedikit paling
                    sedikit 3/5 (tiga per lima) bagian dari jumlah seluruh saham dengan hak suara yang sah dan keputusan
                    sah jika disetujui oleh lebih dari 1/2 (satu per dua) bagian dari seluruh saham dengan hak suara yang
                    hadir dalam RUPSLB .

               Apabila kuorum kehadiran Pemegang Saham Independen dalam RUPSLB kedua pada tanggal 14 Juli
               2026 untuk mengambil keputusan atas Rencana Go Private dan Delisting sebagaimana disyaratkan pada
               di atas tidak tercapai, maka Perseroan dapat melangsungkan RUPSLB Ketiga.
        9.     Sesuai dengan ketentuan dalam Pasal 18 POJK No. 15/2020, bahan mata acara Rapat tersedia sejak
               tanggal Pemanggilan Rapat sampai dengan penyelenggaraan Rapat yang dapat diakses dan diunduh
               melalui situs web Perseroan (https://www.organon.com/indonesia/).




                                                                 Jakarta, 6 Juli 2026
                                                          PT Organon Pharma Indonesia Tbk
                                                                       Direksi

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




                                                     INVITATION
                                 THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                                          PT ORGANON PHARMA INDONESIA Tbk


  In relation to the Extraordinary General Meeting of Shareholders (“EGMS”) of PT Organon Pharma Indonesia Tbk
  (“the Company”) which was held on Tuesday, 23 June 2026 where the EGMS did not reached the attendance
  quorum for the approval of the plan to change the Company’s status from a public company to a private company
  (“Go Private Plan”), we hereby notify that the Company plans to hold a second EGMS, which will be held on:

               Day/Date                  : Tuesday, 14 July 2026
               Time                      : 14.00 WIB - finished
               Place                     : Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21
                                         Setiabudi, Jakarta Selatan, DKI Jakarta

  EGMS Agenda and Explanation of EGMS Agenda:
    Independent Quorum
     1. Approval of the Plan to Change the Company’s Status into a Private Company (“Go Private Plan”),
        which includes:
        a. approval of the change of the Company’s status from a public company to a private company;
        b. approval of the delisting of the Company’s shares from the Indonesia Stock Exchange;
        c. approval of the appointment of supporting professionals required in connection with the Go Private
            Plan; and
        d. the granting of full authority to the Board of Directors of the Company to take any and all actions
            required or deemed necessary in connection with the implementation or completion of the Go Private
            Plan.

               Explanation:
               The Company plans to change its status from a public company to a private company, including the plan
               to delist the Company’s shares from the Indonesia Stock Exchange. The Go Private and Delisting Plan will
               be implemented in accordance with OJK Regulation No. 45 Year 2024 concerning the Development and
               Strengthening of Issuers and Public Companies, as well as Indonesia Stock Exchange Regulation No. I-N
               concerning Delisting and Relisting.

       Ordinary Quorum (Non-Independent)
       2. Approval of the amendment to the Company’s entire Articles of Association in connection with
           the change of the Company’s status from a public company to a private company, including the
           adjustment of the Company’s name.

               Explanation:
               Subject to the approval of the first agenda item mentioned above, [this agenda is for] the approval of the
               amendment to the Company’s entire Articles of Association in connection with the change of the Company’s
               status from a listed public company to a private company, and the granting of authority to the Board of
               Directors of the Company to take all necessary actions to execute the amendment to the Company’s
               Articles of Association.

  Notes
      1.       The Company does not send a separate invitation to the Shareholders of the Company. Based on Article
               52 paragraph (1) Financial Services Authority Regulation No. 15/POJK.04/2020 regarding the Plan and
               Implementation of General Meeting of Shareholders of Public Companies (“POJK No. 15/2020”), this
               invitation is an official invitation for the Company's Shareholders. This invitation can also be seen on the
               Company's website (https://www.msd-indonesia.com).
        2.     Pursuant to Article 7 paragraph (7) of the Company's Articles of Association, those entitled to vote at the
               Meeting are the Company's Shareholders whose names are registered in the Shareholders Register
               (“DPS”) of the Company or the holders of securities account balances in KSEI Collective Custody on
               Thursday, 2 July 2026 at 16.00 WIB.

PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




        3.     For the Shareholders of the Company whose shares are placed in the collective custody of KSEI, a Written
               Confirmation for the Meeting (“KTUR”) can be obtained at the securities company or at the Custodian Bank
               where the Company's Shareholders open their securities accounts.
        4.     Shareholders who are not present can be represented by their proxies through e-proxy as mentioned above
               and/or represented by their proxies at the Meeting by bringing a Power of Attorney provided that members
               of the Board of Directors, members of the Board of Commissioners and employees of the Company can
               act as proxies for the Company's shareholders in This meeting, however, the votes they cast are not taken
               into account in the voting. The Power of Attorney Form can be obtained every working hour at the
               Company's Securities Administration Bureau (“BAE”), Jalan Kyai Caringin No 2-A RT 11/RW 4, Cideng,
               Gambir, Jakarta Pusat 10150, telephone number (021) 22638327, 22639048, and email to:
               ficomindo_br@yahoo.co.id (“BAE”).
        5.     Shareholders or their proxies who will attend the Meeting are requested to bring and submit a copy of valid
               Identity Card or Other Identification to the registration officer before entering the Meeting room.
        6.     Shareholders of companies in the form of legal entities such as Limited Liability Companies, Foundations
               or Pension Funds must bring a complete photocopy of their Articles of Association and the latest
               management structure.
        7.     The proxy form and Independent Shareholder declaration form may be obtained and downloaded from the
               Company's website at https://www.organon.com/indonesia/ or from the office of the Share Registrar (BAE).
               These documents must be duly signed and affixed with the required stamp duty. If the proxy form and
               Independent Shareholder declaration form are executed outside the territory of the Republic of Indonesia,
               they must be legalized by a local public notary and the official representative office of the Government of
               the Republic of Indonesia in the relevant country, or be apostilled in accordance with the applicable
               regulations.
        8.     Attendance and Voting Quorum:
                    •    First Agenda Item: The meeting requires the attendance of Independent Shareholders
                         representing more than 1/2 (one-half) of the total shares carrying valid voting rights held by the
                         Independent Shareholders. The resolution shall be valid if approved by more than 1/2 (one-half)
                         of the total shares carrying valid voting rights held by the Independent Shareholders present at
                         the Second EGMS.
                    •    Second Agenda Item: The meeting requires the attendance of shareholders representing at least
                         3/5 (three-fifths) of the total shares carrying valid voting rights. The resolution shall be valid if
                         approved by more than 1/2 (one-half) of the total shares carrying voting rights present at the
                         EGMS.
               If the attendance quorum of the Independent Shareholders at the Second EGMS to be held on 14 July
               2026 for the purpose of approving the Proposed Go Private and Delisting, as described above, is not
               achieved, the Company may convene a Third Extraordinary General Meeting of Shareholders (Third
               EGMS).

        9.     In accordance with the provisions in Article 18 POJK No. 15/2020, the material for the agenda of the
               Meeting is available from the date of the Meeting Invitation to the convening of the Meeting which can be
               accessed and downloaded through the Company's website (https://www.organon.com/indonesia/).


                                                                 Jakarta, 6 July 2026
                                                          PT Organon Pharma Indonesia Tbk
                                                                  Board of Directors